Connect with us

3 Hot Penny Stocks to Watch in 2022

Can penny stocks continue to make gains in 2022?
The post 3 Hot Penny Stocks to Watch in 2022 appeared first on Penny Stocks to Buy, Picks, News and Information |



Check These 3 Penny Stocks Out For Your 2022 Watchlist 

With 2022 here and in full effect for penny stocks, there are quite a few things for all investors to understand. Right now, we are seeing sizable bullish sentiment following a stellar end to 2021. And while the Omicron variant is still causing upset and instability in the stock market, many believe that 2022 could be a major year for penny stocks and blue chips

To make money with penny stocks, investors need to have a full understanding of what is going on in the stock market. In addition, knowing how to trade penny stocks will be a major asset to your portfolio. If we consider the sheer number of factors impacting stocks right now, we see that there is plenty of momentum to take advantage of. 

[Read More] 4 Penny Stocks To Buy For Under $5 With High Short Interest

With a new year comes the potential to find trends that can be taken advantage of. And while the pandemic may not last forever, the effects of Covid will likely be around for quite some time. Considering all of this, let’s take a look at three hot penny stocks to watch in 2022. 

3 Penny Stocks to Watch in January 2022

  1. Vinco Ventures Inc. (NASDAQ: BBIG
  2. Transocean Ltd. (NYSE: RIG
  3. Zomedica Corp. (NYSE: ZOM

Vinco Ventures Inc. (NASDAQ: BBIG) 

One of the bigger gainers of the day so far is Vinco Ventures. By midday, shares of BBIG stock had shot up by a respectable, 5.2%. However, in the past twelve months, shares of BBIG stock have climbed by over 100% which is no small feat. Now, it’s worth understanding why Vinco Ventures is so popular right now and what the company could have to offer. 

For starters, Vinco is a digital holdings company that has several units of interest. Its wholly-owned, Cryptyde business unit has been a major focus for investors as crypto has gained popularity in the last few years. Cryptyde works in NFT’s, metaverse-related business practices, and more relating to blockchain. In addition to this and one of the main reasons that investors are focused on BBIG stock is its ZVV joint venture with ZASH Global. This venture has an 80% stake in Lomotif as well as complete ownership of the company, Adrizer.

The company has been working to grow the advertising potential of Lomotif, which offers video sharing and is comparable to TikTok. Now, it’s worth understanding that BBIG stock is no stranger to volatility. The company has seen massive price moves in both directions over the past few months. But, if you’re willing to take a risk, BBIG stock could be worth adding to your list of penny stocks to watch. 

Transocean Ltd. (NYSE: RIG) 

Another big gainer today and a company that we’ve covered numerous times in the past few months is Transocean Ltd. Today, shares of RIG stock shot up by over 12%, which is quite substantial considering its 33% twelve-month gain. As an energy stock, Transocean’s price movement is subject to momentum from larger industry news. And today, the oil and gas industry got a boost following an OPEC+ meeting. 

[Read More] Best Penny Stocks to Buy Today? 3 For Your Watchlist in January

The meeting states that output will increase in February which is big news for the industry. In addition to this, the group appointed Haitham al-Ghais as its new secretary-general. Right now, it is hard to see where the energy industry will go. As a result of the Omicron variant, we have seen decreased travel over the last few weeks. While the impact may not be long-term, it should affect the energy industry as a whole in the short term. 

As we’ve seen throughout the pandemic, rising case numbers directly and inversely affect the price of many energy stocks. So, as a pure-play provider of offshore drilling services for oil and gas wells, Transocean has a large exposure to the oil and gas market. Considering all of this, do you think that RIG stock is worth buying this month?


Zomedica Corp. (NYSE: ZOM) 

Zomedica Corp. is a penny stock that has remained quite popular over the past year or so. And with an 11% gain on January 3rd at midday, ZOM stock is once again in the spotlight. While there is no news that is sparking today’s gain, we can look at what Zomedica does and its recent announcements to understand why ZOM is moving up. If you’re not familiar, Zomedica is a veterinary health company that provides a range of diagnostic products. These products are aimed at increasing the efficiency of common diagnostic procedures as well as patient health. 

Recently, the company announced that it would be presenting at the upcoming H.C. Wainwright BioConnect 2022 Conference. This conference will take place on January 10th through the 13th. While this alone is not a major deal, it is enough to look for speculative moves with ZOM stock during that time. Outside of this, many investors view ZOM as a meme stock. This is due to its constant mentions on social media sites such as Reddit and Twitter. And while it only launched its Truforma product last year, the company is still working hard to grow. 

So right now, it seems that a combination of social sentiment and fundamentals are driving ZOM stock’s price. In addition, the pandemic has resulted in more people having domestic pets than in many years prior. So considering all of this information, do you think that Zomedica stock is worth watching or not?


Which Penny Stocks Are on Your 2022 Watchlist?

While 2021 was in no way a banner year for stability, many investors believe that 2022 could be a year to watch for penny stocks. Although it is difficult to try and predict what will happen in the stock market this year, we do know that there is a lot of bullish sentiment abound. 

[Read More] Trending Penny Stocks to Watch After Holiday Season

As always, investors should stay as up-to-date as possible with all the latest news and events going on. Because penny stocks are so speculative, any events are crucial to understanding how penny stocks will move. With all of that in mind, which small caps are on your 2022 watchlist?

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!

The post 3 Hot Penny Stocks to Watch in 2022 appeared first on Penny Stocks to Buy, Picks, News and Information |

Read More

Continue Reading


Part 1: Current State of the Housing Market; Overview for mid-March 2024

Today, in the Calculated Risk Real Estate Newsletter: Part 1: Current State of the Housing Market; Overview for mid-March 2024
A brief excerpt: This 2-part overview for mid-March provides a snapshot of the current housing market.

I always like to star…



Today, in the Calculated Risk Real Estate Newsletter: Part 1: Current State of the Housing Market; Overview for mid-March 2024

A brief excerpt:
This 2-part overview for mid-March provides a snapshot of the current housing market.

I always like to start with inventory, since inventory usually tells the tale!
Here is a graph of new listing from’s February 2024 Monthly Housing Market Trends Report showing new listings were up 11.3% year-over-year in February. This is still well below pre-pandemic levels. From

However, providing a boost to overall inventory, sellers turned out in higher numbers this February as newly listed homes were 11.3% above last year’s levels. This marked the fourth month of increasing listing activity after a 17-month streak of decline.
Note the seasonality for new listings. December and January are seasonally the weakest months of the year for new listings, followed by February and November. New listings will be up year-over-year in 2024, but we will have to wait for the March and April data to see how close new listings are to normal levels.

There are always people that need to sell due to the so-called 3 D’s: Death, Divorce, and Disease. Also, in certain times, some homeowners will need to sell due to unemployment or excessive debt (neither is much of an issue right now).

And there are homeowners who want to sell for a number of reasons: upsizing (more babies), downsizing, moving for a new job, or moving to a nicer home or location (move-up buyers). It is some of the “want to sell” group that has been locked in with the golden handcuffs over the last couple of years, since it is financially difficult to move when your current mortgage rate is around 3%, and your new mortgage rate will be in the 6 1/2% to 7% range.

But time is a factor for this “want to sell” group, and eventually some of them will take the plunge. That is probably why we are seeing more new listings now.
There is much more in the article.

Read More

Continue Reading


RFK Jr. Reveals Vice President Contenders

RFK Jr. Reveals Vice President Contenders

Authored by Jeff Louderback via The Epoch Times,

New York Jets quarterback Aaron Rodgers and former…



RFK Jr. Reveals Vice President Contenders

Authored by Jeff Louderback via The Epoch Times,

New York Jets quarterback Aaron Rodgers and former Minnesota governor and professional wrestler Jesse Ventura are among the potential running mates for independent presidential candidate Robert F. Kennedy Jr., the New York Times reported on March 12.

Citing “two people familiar with the discussions,” the New York Times wrote that Mr. Kennedy “recently approached” Mr. Rodgers and Mr. Ventura about the vice president’s role, “and both have welcomed the overtures.”

Mr. Kennedy has talked to Mr. Rodgers “pretty continuously” over the last month, according to the story. The candidate has kept in touch with Mr. Ventura since the former governor introduced him at a February voter rally in Tucson, Arizona.

Stefanie Spear, who is the campaign press secretary, told The Epoch Times on March 12 that “Mr. Kennedy did share with the New York Times that he’s considering Aaron Rodgers and Jesse Ventura as running mates along with others on a short list.”

Ms. Spear added that Mr. Kennedy will name his running mate in the upcoming weeks.

Former Democrat presidential candidates Andrew Yang and Tulsi Gabbard declined the opportunity to join Mr. Kennedy’s ticket, according to the New York Times.

Mr. Kennedy has also reportedly talked to Sen. Rand Paul (R-Ky.) about becoming his running mate.

Last week, Mr. Kennedy endorsed Mr. Paul to replace Sen. Mitch McConnell (R-Ky.) as the Senate Minority Leader after Mr. McConnell announced he would step down from the post at the end of the year.

CNN reported early on March 13 that Mr. Kennedy’s shortlist also includes motivational speaker Tony Robbins, Discovery Channel Host Mike Rowe, and civil rights attorney Tricia Lindsay. The Washington Post included the aforementioned names plus former Republican Massachusetts senator and U.S. Ambassador to New Zealand and Samoa, Scott Brown.

In April 2023, Mr. Kennedy entered the Democrat presidential primary to challenge President Joe Biden for the party’s 2024 nomination. Claiming that the Democrat National Committee was “rigging the primary” to stop candidates from opposing President Biden, Mr. Kennedy said last October that he would run as an independent.

This year, Mr. Kennedy’s campaign has shifted its focus to ballot access. He currently has qualified for the ballot as an independent in New Hampshire, Utah, and Nevada.

Mr. Kennedy also qualified for the ballot in Hawaii under the “We the People” party.

In January, Mr. Kennedy’s campaign said it had filed paperwork in six states to create a political party. The move was made to get his name on the ballots with fewer voter signatures than those states require for candidates not affiliated with a party.

The “We the People” party was established in five states: California, Delaware, Hawaii, Mississippi, and North Carolina. The “Texas Independent Party” was also formed.

A statement by Mr. Kennedy’s campaign reported that filing for political party status in the six states reduced the number of signatures required for him to gain ballot access by about 330,000.

Ballot access guidelines have created a sense of urgency to name a running mate. More than 20 states require independent and third-party candidates to have a vice presidential pick before collecting and submitting signatures.

Like Mr. Kennedy, Mr. Ventura is an outspoken critic of COVID-19 vaccine mandates and safety.

Mr. Ventura, 72, gained acclaim in the 1970s and 1980s as a professional wrestler known as Jesse “the Body” Ventura. He appeared in movies and television shows before entering the Minnesota gubernatorial race as a Reform Party headliner. He was a longshot candidate but prevailed and served one term.

Former pro wrestler Jesse Ventura in Washington on Oct. 4, 2013. (Brendan Smialowski/AFP via Getty Images)

In an interview on a YouTube podcast last December, Mr. Ventura was asked if he would accept an offer to run on Mr. Kennedy’s ticket.

“I would give it serious consideration. I won’t tell you yes or no. It will depend on my personal life. Would I want to commit myself at 72 for one year of hell (campaigning) and then four years (in office)?” Mr. Ventura said with a grin.

Mr. Rodgers, who spent his entire career as a quarterback for the Green Bay Packers before joining the New York Jets last season, remains under contract with the Jets. He has not publicly commented about joining Mr. Kennedy’s ticket, but the four-time NFL MVP endorsed him earlier this year and has stumped for him on podcasts.

The 40-year-old Rodgers is still under contract with the Jets after tearing his Achilles tendon in the 2023 season opener and being sidelined the rest of the year. The Jets are owned by Woody Johnson, a prominent donor to former President Donald Trump who served as U.S. Ambassador to Britain under President Trump.

Since the COVID-19 vaccine was introduced, Mr. Rodgers has been outspoken about health issues that can result from taking the shot. He told podcaster Joe Rogan that he has lost friends and sponsorship deals because of his decision not to get vaccinated.

Quarterback Aaron Rodgers of the New York Jets talks to reporters after training camp at Atlantic Health Jets Training Center in Florham Park, N.J., on July 26, 2023. (Rich Schultz/Getty Images)

Earlier this year, Mr. Rodgers challenged Kansas City Chiefs tight end Travis Kelce and Dr. Anthony Fauci to a debate.

Mr. Rodgers referred to Mr. Kelce, who signed an endorsement deal with vaccine manufacturer Pfizer, as “Mr. Pfizer.”

Dr. Fauci served as director of the National Institute of Allergy and Infectious Diseases from 1984 to 2022 and was chief medical adviser to the president from 2021 to 2022.

When Mr. Kennedy announces his running mate, it will mark another challenge met to help gain ballot access.

“In some states, the signature gathering window is not open. New York is one of those and is one of the most difficult with ballot access requirements,” Ms. Spear told The Epoch Times.

“We need our VP pick and our electors, and we have to gather 45,000 valid signatures. That means we will collect 72,000 since we have a 60 percent buffer in every state,” she added.

The window for gathering signatures in New York opens on April 16 and closes on May 28, Ms. Spear noted.

“Mississippi, North Carolina, and Oklahoma are the next three states we will most likely check off our list,” Ms. Spear added. “We are confident that Mr. Kennedy will be on the ballot in all 50 states and the District of Columbia. We have a strategist, petitioners, attorneys, and the overall momentum of the campaign.”

Tyler Durden Wed, 03/13/2024 - 15:45

Read More

Continue Reading


Pharma industry reputation remains steady at a ‘new normal’ after Covid, Harris Poll finds

The pharma industry is hanging on to reputation gains notched during the Covid-19 pandemic. Positive perception of the pharma industry is steady at 45%…



The pharma industry is hanging on to reputation gains notched during the Covid-19 pandemic. Positive perception of the pharma industry is steady at 45% of US respondents in 2023, according to the latest Harris Poll data. That’s exactly the same as the previous year.

Pharma’s highest point was in February 2021 — as Covid vaccines began to roll out — with a 62% positive US perception, and helping the industry land at an average 55% positive sentiment at the end of the year in Harris’ 2021 annual assessment of industries. The pharma industry’s reputation hit its most recent low at 32% in 2019, but it had hovered around 30% for more than a decade prior.

Rob Jekielek

“Pharma has sustained a lot of the gains, now basically one and half times higher than pre-Covid,” said Harris Poll managing director Rob Jekielek. “There is a question mark around how sustained it will be, but right now it feels like a new normal.”

The Harris survey spans 11 global markets and covers 13 industries. Pharma perception is even better abroad, with an average 58% of respondents notching favorable sentiments in 2023, just a slight slip from 60% in each of the two previous years.

Pharma’s solid global reputation puts it in the middle of the pack among international industries, ranking higher than government at 37% positive, insurance at 48%, financial services at 51% and health insurance at 52%. Pharma ranks just behind automotive (62%), manufacturing (63%) and consumer products (63%), although it lags behind leading industries like tech at 75% positive in the first spot, followed by grocery at 67%.

The bright spotlight on the pharma industry during Covid vaccine and drug development boosted its reputation, but Jekielek said there’s maybe an argument to be made that pharma is continuing to develop innovative drugs outside that spotlight.

“When you look at pharma reputation during Covid, you have clear sense of a very dynamic industry working very quickly and getting therapies and products to market. If you’re looking at things happening now, you could argue that pharma still probably doesn’t get enough credit for its advances, for example, in oncology treatments,” he said.

Read More

Continue Reading